Mobile

Result of your search per sponsor: Johannes Drach, MD

Woman and Man Max 99 years
Johannes Drach, MD Update Il y a 4 ans

Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell Lymphoma Mantle cell lymphoma (MCL) remains difficult to treat by standard treatment approaches. Novel drugs have shown promising results in early clinical evaluations. In the current trial, we inv...

  • Country Austria
  • organs None
  • Specialty None
unknown
More information